Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 23,825,802
- Share change
- +369,931
- Total reported value
- $107,940,708
- Put/Call ratio
- 431%
- Price per share
- $4.53
- Number of holders
- 66
- Value change
- -$515,812
- Number of buys
- 33
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05156V102:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
4.4%
|
5,838,831
|
$36,610,000 | — | 30 Sep 2017 | |
| NEA Management Company, LLC |
13F
|
Company |
3.6%
|
4,808,483
|
$30,149,000 | — | 30 Sep 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.4%
|
1,797,400
|
$11,270,000 | — | 30 Sep 2017 | |
| Polar Capital LLP |
13F
|
Company |
1.2%
|
1,618,352
|
$10,147,000 | — | 30 Sep 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.94%
|
1,250,000
|
$7,838,000 | — | 30 Sep 2017 | |
| Vivo Capital, LLC |
13F
|
Company |
0.91%
|
1,213,290
|
$7,607,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.66%
|
874,911
|
$5,486,000 | — | 30 Sep 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.51%
|
681,517
|
$4,273,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
571,552
|
$3,585,000 | — | 30 Sep 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.38%
|
500,000
|
$3,135,000 | — | 30 Sep 2017 | |
| Crawford Lake Capital Management, LLC |
13F
|
Company |
0.34%
|
455,656
|
$2,857,000 | — | 30 Sep 2017 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.28%
|
375,000
|
$2,351,000 | — | 30 Sep 2017 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.27%
|
352,500
|
$2,210,000 | — | 30 Sep 2017 | |
| Redmile Group, LLC |
13F
|
Company |
0.25%
|
332,310
|
$2,084,000 | — | 30 Sep 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
307,676
|
$1,929,000 | — | 30 Sep 2017 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.2%
|
261,863
|
$1,642,000 | — | 30 Sep 2017 | |
| Abingworth LLP |
13F
|
Company |
0.19%
|
252,129
|
$1,581,000 | — | 30 Sep 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.16%
|
211,569
|
$1,327,000 | — | 30 Sep 2017 | |
| IRONWOOD INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.14%
|
192,177
|
$1,205,000 | — | 30 Sep 2017 | |
| Sculptor Capital LP |
13F
|
Company |
0.14%
|
185,100
|
$1,161,000 | — | 30 Sep 2017 | |
| Creative Planning |
13F
|
Company |
0.11%
|
150,200
|
$942,000 | — | 30 Sep 2017 | |
| Kazazian Asset Management, LLC |
13F
|
Company |
0.11%
|
139,937
|
$877,000 | — | 30 Sep 2017 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.1%
|
127,312
|
$798,000 | — | 30 Sep 2017 | |
| S.c.a. Candriam |
13F
|
Individual |
0.09%
|
118,000
|
$740,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
92,835
|
$582,000 | — | 30 Sep 2017 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.06%
|
82,163
|
$515,000 | — | 30 Sep 2017 | |
| INVESTMENT CENTERS OF AMERICA INC |
13F
|
Company |
0.05%
|
60,000
|
$376,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
58,301
|
$366,000 | — | 30 Sep 2017 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
55,500
|
$348,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
53,652
|
$335,000 | — | 30 Sep 2017 | |
| Parallax Volatility Advisers, L.P. |
13F
|
Company |
0.04%
|
49,702
|
$312,000 | — | 30 Sep 2017 | |
| Cutler Capital Management, LLC |
13F
|
Company |
0.03%
|
40,000
|
$251,000 | — | 30 Sep 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
39,700
|
$249,000 | — | 30 Sep 2017 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.03%
|
38,900
|
$244,000 | — | 30 Sep 2017 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
37,009
|
$232,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
26,595
|
$166,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
24,941
|
$156,000 | — | 30 Sep 2017 | |
| STATE OF MICHIGAN RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
22,500
|
$141,000 | — | 30 Sep 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
19,100
|
$120,000 | — | 30 Sep 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
16,501
|
$104,000 | — | 30 Sep 2017 | |
| NTV ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
15,000
|
$94,000 | — | 30 Sep 2017 | |
| Noven Financial Group, Inc. |
13F
|
Company |
0.01%
|
14,000
|
$88,000 | — | 30 Sep 2017 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
12,726
|
$80,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
11,900
|
$75,000 | — | 30 Sep 2017 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
10,041
|
$63,000 | — | 30 Sep 2017 | |
| LEVIN CAPITAL STRATEGIES, L.P. |
13F
|
Company |
0.01%
|
10,000
|
$63,000 | — | 30 Sep 2017 | |
| BROWN BROTHERS HARRIMAN & CO |
13F
|
Company |
0%
|
6,500
|
$41,000 | — | 30 Sep 2017 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
5,300
|
$33,000 | — | 30 Sep 2017 | |
| NumerixS Investment Technologies Inc |
13F
|
Company |
0%
|
4,600
|
$29,000 | — | 30 Sep 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,500
|
$20,000 | — | 30 Sep 2017 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2017
As of 31 Dec 2017,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,825,802 shares.
The largest 10 holders included
NEA Management Company, LLC, FMR LLC, Polar Capital LLP, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, Vivo Capital, LLC, GOLDMAN SACHS GROUP INC, BlackRock Inc., Alyeska Investment Group, L.P., and Point72 Asset Management, L.P..
This page lists
66
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
59
Q4 2017 holders
66
Holder diff
7
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.